Angiogenesis and arteriogenesis - Not yet for prescription

Zeitschrift fur Kardiologie

Volumn 89, Issue 3, 2000, Pages 239-244

  Helisch, A ^a   Schaper, W ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Collateral vessels; Coronary heart disease; Growth factors; Ischemic vascular disease; Peripheral vascular disease

Indexed keywords

ALGINIC ACID; FIBROBLAST GROWTH FACTOR 1; HEPARIN; PLACEBO; PLASMID DNA; RECOMBINANT DNA; RECOMBINANT VASCULOTROPIN; VIRUS VECTOR;

ANGIOGENESIS; ARTICLE; BUERGER DISEASE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; GENE THERAPY; HEART MUSCLE; HUMAN; ISCHEMIC HEART DISEASE; PERIPHERAL VASCULAR DISEASE; PHASE 1 CLINICAL TRIAL;

ANIMALS; CLINICAL TRIALS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; COLLATERAL CIRCULATION; CORONARY DISEASE; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GROWTH SUBSTANCES; HEMODYNAMIC PROCESSES; HUMANS; LYMPHOKINES; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; PROTEIN ISOFORMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034128426     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050477     Document Type: Article

References (37)

1. 1. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40-50
2. 2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
3. 3. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 85:221-228
4. 4. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 18:3964-3972
5. 5. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123
6. 6. Browder T, Folkman J, Pirie-Shepherd S (2000) The hemostatic system as a regulator of angiogenesis. J Biol Chem 275:1521-1524
7. 7. Ferrara N, Alitalo K (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5:1359-1364
8. 8. Ferrara N, Gerber HP (1999) The vascular endothelial growth factor family. In: Ware JA, Simons M (ed) Angiogenesis and Cardiovascular Disease. Oxford University Press, New York, Oxford, pp 101-127
9. 9. Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763
10. 10. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Sasayama S (1996) Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 94:610-613
11. 11. Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277:48-50
12. 12. Helisch A, Ware JA (1999) Therapeutic angiogenesis in ischemic heart disease. Thromb Haemost 82:772-780
13. 13. Hendel RC, Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Bonow RO (2000) Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 101:118-121
14. 14. Henry TD, Annex BH, Azrin MA, McKendall GR, Willerson JT, Hendel RC, Giordano F, Klein R, Gibson M, Berman DS, Luce CA, McCluskey ER (1999) Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis. Circulation 100 (Suppl. I):I-476
15. 15. Htun P, Ito WD, Hoefer IE, Schaper J, Schaper W (1998) Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium. J Mol Cell Cardiol 30:867-877
16. 16. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF (1998) Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28:964-973
17. 17. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370-374
18. 18. Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W (1997) Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 273:H1255-1265
19. 19. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829-837
20. 20. Kornowski R, Fuchs S, Leon MB, Epstein SE (2000) Delivery Strategies to achieve therapeutic myocardial angiogenesis. Circulation 101:454-458
21. 21. Kranz A, Rau C, Kochs M, Waltenberger J (2000) Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol 32:65-72
22. 22. Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, Gold JP, Simons M (1999) Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, place-bo-controlled trial. Circulation 100: 1865-1871
23. 23. Li J, Post M, Volk R, Gao Y, Li M, Metais C, Sato K, Tsai J, Aird W, Rosenberg RD, Hampton TG, Sellke F, Carmeliet P, Simons M (2000) PR39, a peptide regulator of angiogenesis. Nat Med 6:49-55
24. 24. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J (1999) Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99: 1726-1732
25. 25. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
26. 26. Risau W, Flamme I (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91
27. 27. Rohovsky S, Kearney M, Pieczek A, Rosenfield K, Schainfeld R, D'Amore PA, Isner JM (1996) Elevated levels of basic fibroblast growth factor in patients with limb ischemia. Am Heart J 132:1015-1019
28. 28. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474
29. 29. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126
30. 30. Schaper W, Buschmann I (1999) Collateral circulation and diabetes. Circulation 99:2224-2226
31. 31. Schaper W, Piek JJ, Munoz-Chapuli R, Wolf C, Ito W (1999) Collateral circulation of the heart. In: Ware JA, Simons M (ed) Angiogenesis and Cardiovascular Disease. Oxford University Press, New York, Oxford, pp 159-198
32. 32. Schumacher B, Pecher P, von Specht BU, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97: 645-650
33. 33 Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, Isner JM (1999) Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68:830-836
34. 34. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514
35. 35. Topper JN, Gimbrone MA, Jr. (1999) Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today 5:40-46
36. 36. Ware JA, Simons M (1997) Angiogenesis in ischemic heart disease. Nat Med 3:158-164
37. 37. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403